Literature DB >> 3809404

The radiation response of SCCVII tumor cells in C3H/He mice varies with the irradiation conditions.

Y Shibamoto, K Sasai, M Abe.   

Abstract

The radiation response of SCCVII tumor cells in C3H/He mice under various irradiation conditions was studied using an in vivo-in vitro assay. When tumor-bearing mice were irradiated without anesthesia or physical restraint, the tumor had a hypoxic fraction of 5.4%. Both anesthesia and immobilization of the tumor-bearing leg with adhesive tape produced significant increases in the hypoxic fraction (23 and 28%, respectively). Restraining the mouse in a jig without immobilizing the tumor-bearing leg also increased the hypoxic fraction (13%).

Entities:  

Mesh:

Year:  1987        PMID: 3809404

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  9 in total

1.  The combined antitumour effect of a new 5-fluorouracil derivative, BOF-A2, and radiation in vivo.

Authors:  R Murata; Y Shibamoto; S Miyauchi; M Hirohashi; T Takagi; K Sasai; N Oya; M Hiraoka
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.

Authors:  K Sasai; Y Shibamoto; M Takahashi; L Zhou; H Hori; H Nagasawa; T Shibata; S Inayama; M Abe
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  The in vivo study on the radiobiologic effect of prolonged delivery time to tumor control in C57BL mice implanted with Lewis lung cancer.

Authors:  Xin Wang; Xiao-Peng Xiong; Jiade Lu; Guo-Pei Zhu; Shao-Qin He; Chao-Su Hu; Hong-Mei Ying
Journal:  Radiat Oncol       Date:  2011-01-12       Impact factor: 3.481

4.  Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.

Authors:  Y Shibamoto; R Murata; S Miyauchi; M Hirohashi; T Takagi; K Sasai; T Shibata; N Oya; M Takahashi
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

5.  Biological effects of hydrogen peroxide administered intratumorally with or without irradiation in murine tumors.

Authors:  Taiki Takaoka; Yuta Shibamoto; Masayuki Matsuo; Chikao Sugie; Taro Murai; Yasutaka Ogawa; Akifumi Miyakawa; Yoshihiko Manabe; Takuhito Kondo; Koichiro Nakajima; Dai Okazaki; Takahiro Tsuchiya
Journal:  Cancer Sci       Date:  2017-07-21       Impact factor: 6.716

6.  A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.

Authors:  K Sasai; Y Shibamoto; M Takahashi; M Abe; J Wang; L Zhou; S Nishimoto; T Kagiya
Journal:  Jpn J Cancer Res       Date:  1989-11

7.  In vitro and in vivo studies on radiobiological effects of prolonged fraction delivery time in A549 cells.

Authors:  Ling Jiang; Xiao-Peng Xiong; Chao-Su Hu; Zhou-Luo Ou; Guo-Pei Zhu; Hong-Mei Ying
Journal:  J Radiat Res       Date:  2012-10-22       Impact factor: 2.724

Review 8.  Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?

Authors:  Yuta Shibamoto; Akifumi Miyakawa; Shinya Otsuka; Hiromitsu Iwata
Journal:  J Radiat Res       Date:  2016-03-22       Impact factor: 2.724

9.  Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.

Authors:  T Shibata; Y Shibamoto; K Sasai; N Oya; R Murata; T Takagi; M Hiraoka; M Abe
Journal:  Jpn J Cancer Res       Date:  1996-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.